Form 8-K - Current report:
SEC Accession No. 0001641172-25-001486
Filing Date
2025-03-31
Accepted
2025-03-31 08:00:26
Documents
15
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39338
2 ex99-1.htm EX-99.1 35209
3 ex99-1_001.jpg GRAPHIC 10751
  Complete submission text file 0001641172-25-001486.txt   271919

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE envb-20250331.xsd EX-101.SCH 3012
5 XBRL LABEL FILE envb-20250331_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE envb-20250331_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3826
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 25788981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)